A Team Approach to Improving Outcomes in RA: Clinicians, Patients, and Coaches

0 reviews

Haymarket Medical Education

1.50 hours

PROGRAM DESCRIPTION
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting over 1.3 million Americans and approximately 1% of the global population.1 Many treatment options are available to treat RA, and these agents may be used as monotherapy, as sequential treatment strategies, or as combination treatment. To successfully treat patients with RA, clinicians must be aware of the various treatment strategies outlined in the ACR guidelines and clinical evidence that supports these treat-to-target approaches. The management of RA is complex and requires the involvement of the entire treatment team—that includes the patient—in order to maximize the benefits of existing treatment approaches, incorporate new treatments when appropriate, and ensure the healthcare needs of all patients with RA are met. This webcast features a panel discussion moderated by Leonard Calabrese, DO with audio input from patients with RA, and video interviews from RA team care members at the Cleveland Clinic.Reference1. Rheumatoid Arthritis Support Network. Rheumatoid arthritis facts and figures. Rheumatoid Arthritis Support Network Website. https://www.rheumatoid....

EDUCATIONAL OBJECTIVES
At the end of this CME/CE activity, participants should be able to:Physicians/PAsAlign treatment decisions with ACR recommendations which support a treat-to-target approach in the care of patients with RACritically appraise DMARD monotherapy treatment options, including JAK-inhibitors in the care of patients with moderate-to-severe RAIntegrate one best practice that can be utilized by the multidisciplinary care team to monitor for signs and symptoms of methotrexate intolerance and medication nonadherenceCNE/CPEDescribe treatment decisions that align with ACR recommendations which support a treat-to-target approach in the care of patients with RACritically appraise DMARD monotherapy treatment options, including JAK-inhibitors in the care of patients with moderate-to-severe RAIdentify best practices that can be utilized by the multidisciplinary care team to monitor for signs and symptoms of methotrexate intolerance and medication nonadherence